Viability means the ability of something to survive, function, or develop successfully. In biology and medicine, it refers to whether a cell, seed, or organism is alive and capable of sustaining life. The term comes up most often in two contexts: laboratory science, where researchers test whether cells are alive or dead, and pregnancy, where it describes the point at which a fetus could potentially survive outside the womb. Each use carries specific criteria worth understanding.
Viability in Biology: Alive and Functioning
At its most basic, viability means a cell or organism is metabolically active. A viable cell produces energy, maintains an intact membrane, and carries out the chemical reactions that keep it functioning. In a lab setting, researchers measure viability by testing for signs of this activity, such as enzyme function, energy production, and membrane integrity. A cell that fails these tests is dead or dying, even if it still looks intact under a microscope.
This concept extends across living things. In agriculture, seed viability determines whether a seed can germinate and grow into a plant. Scientists test this using a colorless chemical that living tissue converts into a red dye. Seeds with active cellular respiration turn red; dead seeds stay colorless. The underlying principle is the same one used in cell research: if the internal machinery is running, the organism is viable.
Bacteria That Are Alive but Undetectable
One fascinating wrinkle in microbiology is the “viable but nonculturable” state. Some bacteria, when exposed to harsh conditions like extreme temperatures, nutrient starvation, or sharp changes in acidity, enter a kind of dormancy. They’re still metabolically active, still technically alive, but they won’t grow on the standard lab plates used to detect them. This matters for food safety and public health because these bacteria can retain their ability to cause disease even though routine testing misses them entirely.
Fetal Viability: When Survival Outside the Womb Becomes Possible
In medicine, viability most often refers to the gestational age at which a fetus has a reasonable chance of surviving if born. There is no single, universally agreed-upon cutoff. The World Health Organization sets the lower limit at 22 weeks of gestation, with a minimum birth weight of about 500 grams (roughly 1.1 pounds) and a length of 25 centimeters. Many hospitals and medical organizations use 24 weeks as a more practical threshold, the point at which survival with intensive medical support becomes meaningfully likely.
The period between 20 and 26 weeks is often called the “periviable” period. Outcomes during this window change dramatically from week to week. Deliveries before 23 weeks carry a survival rate of only 5 to 6 percent, and nearly all survivors face severe complications. At 23 weeks, survival to hospital discharge ranges from 23 to 27 percent. By 24 weeks, that range climbs to 42 to 59 percent. At 25 weeks, 67 to 76 percent of infants survive. A large international study of infants born at 22 and 23 weeks found that survival rates varied enormously between hospitals and countries, ranging from 9 to 64 percent at 22 weeks and 16 to 80 percent at 23 weeks, depending on the center’s resources and treatment approach.
Before 20 weeks, delivery is classified as a miscarriage. A fetus weighing less than 500 grams is generally considered nonviable regardless of gestational age.
Why Gestational Age Alone Doesn’t Decide Viability
Gestational age is the single most important factor, but it’s far from the only one. The American College of Obstetricians and Gynecologists (ACOG) emphasizes that there is no test that can definitively determine whether a fetus will survive outside the uterus. Viability is a clinical judgment, not a diagnosis.
Several other factors shift the odds significantly. Female infants tend to do better than males at the same gestational age. Higher birth weight improves outcomes even within the same week of pregnancy. Singleton births (one baby, not twins or triplets) carry lower risk. The circumstances around delivery matter too: whether labor was spontaneous or induced, whether complications like infection are present, and whether a neonatal intensive care team is available at the hospital.
Perhaps most strikingly, the attitudes and treatment intensity of the medical team influence survival. A hospital that actively resuscitates and treats infants born at 22 weeks will report higher survival rates at that age than one that focuses primarily on comfort care. This explains why survival statistics vary so widely between institutions and countries for the same gestational age.
Medical Interventions That Shift the Threshold
One of the most significant advances in improving outcomes for extremely preterm infants is the use of corticosteroid medications given to the pregnant person before delivery. These drugs accelerate the development of the fetal lungs and other organs, reducing the need for respiratory support after birth. ACOG recommends a course of corticosteroids for pregnancies at risk of preterm delivery between 24 and 34 weeks, and it may be considered as early as 23 weeks based on the family’s wishes regarding resuscitation.
The benefit peaks between 2 and 7 days after the first dose, so timing matters. For pregnancies at risk of late preterm birth (34 to 37 weeks), corticosteroids still reduce respiratory complications. A repeat course can be considered if the first was given more than 14 days earlier and the risk of preterm delivery persists. These interventions, along with improvements in neonatal intensive care technology, are the main reason the boundary of viability has gradually shifted earlier over the past few decades.
Viability as a Legal and Ethical Concept
Outside the clinical setting, viability carries legal weight. In many jurisdictions, the point of fetal viability marks a legal boundary for pregnancy termination, with different rules applying before and after that threshold. This is where the medical ambiguity of the term creates real tension: the law often treats viability as a fixed line, while medicine treats it as a probability that shifts with individual circumstances.
ACOG’s position is that viability depends on many complex factors and cannot be reduced to a single gestational age. A 23-week fetus in a hospital with a specialized neonatal unit has a meaningfully different prognosis than one delivered in a facility without those resources. The gap between how law and medicine use the word “viability” continues to shape debates around reproductive health policy worldwide.